KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022)

Historic Liabilities from Discontinued Operations for Labcorp Holdings (LH) over the last 3 years, with Q4 2022 value amounting to $898.9 million.

Labcorp Holdings' Liabilities from Discontinued Operations changed N/A to $898.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $898.9 million, marking a year-over-year change of. This contributed to the annual value of $898.9 million for FY2022, which is N/A changed from last year.
Labcorp Holdings' Liabilities from Discontinued Operations amounted to $898.9 million in Q4 2022.
Labcorp Holdings' Liabilities from Discontinued Operations' 5-year high stood at $898.9 million during Q4 2022, with a 5-year trough of $82.4 million in Q2 2018.